Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henning Ulrich

Showing results (21-30 of 283) with videos related to

Pageof 29
Sort By:
Purinergic Signalling|January 20, 2025
Purinergic signaling in health: special issue of purines 2022 in BrazilHenning Ulrich, Carla I Tasca, Claudiana Lameu
Journal of Pharmaceutical and Biomedical Analysis|May 14, 2013
Nucleic acid aptamers as high affinity ligands in biotechnology and biosensoricsTina Šmuc, Il-Young Ahn, Henning Ulrich
Cell Communication and Signaling : CCS|February 19, 2013
Implications of purinergic receptor-mediated intracellular calcium transients in neural differentiationTalita Glaser, Rodrigo R Resende, Henning Ulrich
Stem Cell Reviews and Reports|May 1, 2012
Extrinsic purinergic regulation of neural stem/progenitor cells: implications for CNS development and repairHenning Ulrich, Maria P Abbracchio, Geoffrey Burnstock
Expert Opinion on Therapeutic Patents|October 27, 2009
Aptamers: from bench side research towards patented molecules with therapeutic applicationsParomita Majumder, Katia N Gomes, Henning Ulrich
Purinergic Signalling|May 15, 2023
Hematopoietic stem cells on the crossroad between purinergic signaling and innate immunityStephanie Franczak, Henning Ulrich, Mariusz Z Ratajczak
Purinergic Signalling|September 25, 2024
Purinergic signaling in liver disease: calcium signaling and induction of inflammationHenning Ulrich, Talita Glaser, Andrew P Thomas
Recent Patents on CNS Drug Discovery|January 29, 2008
Is there a rational approach for increasing drug specificity? Considerations on CNS target choice and validationRodrigo R Resende, Henning Ulrich, Marcella Faria
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|June 8, 2020
Dengue Fever, COVID-19 (SARS-CoV-2), and Antibody-Dependent Enhancement (ADE): A PerspectiveHenning Ulrich, Micheli M Pillat, Attila Tárnok
Journal of Separation Science|May 28, 2009
Recognition of biomarkers and cell-specific molecular signatures: aptamers as capture agentsArthur A Nery, Carsten Wrenger, Henning Ulrich
Pageof 29

Showing results (21-30 of 283) with videos related to

Sort By:
Pageof 29
Purinergic Signalling|January 20, 2025
Purinergic signaling in health: special issue of purines 2022 in BrazilHenning Ulrich, Carla I Tasca, Claudiana Lameu
Journal of Pharmaceutical and Biomedical Analysis|May 14, 2013
Nucleic acid aptamers as high affinity ligands in biotechnology and biosensoricsTina Šmuc, Il-Young Ahn, Henning Ulrich
Cell Communication and Signaling : CCS|February 19, 2013
Implications of purinergic receptor-mediated intracellular calcium transients in neural differentiationTalita Glaser, Rodrigo R Resende, Henning Ulrich
Stem Cell Reviews and Reports|May 1, 2012
Extrinsic purinergic regulation of neural stem/progenitor cells: implications for CNS development and repairHenning Ulrich, Maria P Abbracchio, Geoffrey Burnstock
Expert Opinion on Therapeutic Patents|October 27, 2009
Aptamers: from bench side research towards patented molecules with therapeutic applicationsParomita Majumder, Katia N Gomes, Henning Ulrich
Purinergic Signalling|May 15, 2023
Hematopoietic stem cells on the crossroad between purinergic signaling and innate immunityStephanie Franczak, Henning Ulrich, Mariusz Z Ratajczak
Purinergic Signalling|September 25, 2024
Purinergic signaling in liver disease: calcium signaling and induction of inflammationHenning Ulrich, Talita Glaser, Andrew P Thomas
Recent Patents on CNS Drug Discovery|January 29, 2008
Is there a rational approach for increasing drug specificity? Considerations on CNS target choice and validationRodrigo R Resende, Henning Ulrich, Marcella Faria
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|June 8, 2020
Dengue Fever, COVID-19 (SARS-CoV-2), and Antibody-Dependent Enhancement (ADE): A PerspectiveHenning Ulrich, Micheli M Pillat, Attila Tárnok
Journal of Separation Science|May 28, 2009
Recognition of biomarkers and cell-specific molecular signatures: aptamers as capture agentsArthur A Nery, Carsten Wrenger, Henning Ulrich
Pageof 29